We're advancing a robust product pipeline through our state-of-the-art platforms in cancer and infectious disease. Our focus is on drug discovery and early drug development, with an eye towards a future that reimagines the way cancer and infectious diseases are treated - and even cured.
Subscribe to our Newsletter
Be the first to know about news, milestones and events at Evaxion by subscribing to our newsletter. You'll only hear from us when it's important, and can unsubscribe at any time.